{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:47:58Z","timestamp":1768002478923,"version":"3.49.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>IL-6 plays a role in cancer pathogenesis via its connection to proteins involved in the formation of desmoplastic stroma and to immunosuppression by driving differentiation of myeloid suppressor cells together with TGF-\u03b2. Inhibition of IL-6 signaling in the tumor microenvironment may, thus, limit desmoplasia and myeloid suppressor cell differentiation. CD40 signaling can further revert myeloid cell differentiation toward antitumor active phenotypes. Hence, the simultaneous use of IL-6 blockade with CD40 stimuli may tilt the tumor microenvironment to promote antitumor immune responses. In this paper, we evaluated the mechanisms of LOAd713, an oncolytic adenovirus designed to block IL-6R signaling and to provide myeloid cell activation via a trimerized membrane-bound isoleucine zipper (TMZ) CD40L. LOAd713-infected pancreatic cancer cells were killed by oncolysis, whereas infection of stellate cells reduced factors involved in stroma formation, including TGF-\u03b2-1 and collagen type I. Virus infection prevented IL-6\/GM-CSF\u2013mediated differentiation of myeloid suppressors, but not CD163 macrophages, whereas infection of dendritic cells led to upregulation of maturation markers, including CD83, CD86, IL-12p70, and IFN-\u03b3. Further, IL-6R blockade prevented upregulation of programed death ligand 1 (PD-L1) and PD-1 on the stimulated dendritic cells. These results suggest that LOAd713 can kill infected tumor cells and has the capacity to affect the tumor microenvironment by stimulating stellate cells and myeloid suppressors with TMZ-CD40L and IL-6R blockade. Gene transfer of murine TMZ-CD40L prolonged survival in an animal model. LOAd713 may be an interesting therapeutic option for cancers connected to IL-6 signaling, such as pancreatic cancer.<\/jats:p>","DOI":"10.4049\/jimmunol.1800717","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T20:46:19Z","timestamp":1546893979000},"page":"787-798","source":"Crossref","is-referenced-by-count":40,"title":["IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-\u03b2, Collagen Type I, and PD-L1\/PD-1"],"prefix":"10.1093","volume":"202","author":[{"given":"Emma","family":"Eriksson","sequence":"first","affiliation":[{"name":"Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University , 751 85 Uppsala ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1677-4230","authenticated-orcid":false,"given":"Ioanna","family":"Milenova","sequence":"additional","affiliation":[{"name":"Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University , 751 85 Uppsala ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4385-7568","authenticated-orcid":false,"given":"Jessica","family":"Wenthe","sequence":"additional","affiliation":[{"name":"Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University , 751 85 Uppsala ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9957-3105","authenticated-orcid":false,"given":"Rafael","family":"Moreno","sequence":"additional","affiliation":[{"name":"L\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge\u2013Institut Catal\u00e0 d\u2019Oncologia, L\u2019Hospitalet de Llobregat , 08908 Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Alemany","sequence":"additional","affiliation":[{"name":"L\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge\u2013Institut Catal\u00e0 d\u2019Oncologia, L\u2019Hospitalet de Llobregat , 08908 Barcelona ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8583-6138","authenticated-orcid":false,"given":"Angelica","family":"Loskog","sequence":"additional","affiliation":[{"name":"Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University , 751 85 Uppsala ,","place":["Sweden"]},{"name":"Lokon Pharma AB , 751 83 Uppsala ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"2025030417560371700_r1","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/gutjnl-2015-309304","article-title":"Stromal biology and therapy in pancreatic cancer: a changing paradigm","volume":"64","author":"Neesse","year":"2015","journal-title":"Gut"},{"key":"2025030417560371700_r2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00006676-200410000-00002","article-title":"Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells","volume":"29","author":"Apte","year":"2004","journal-title":"Pancreas"},{"key":"2025030417560371700_r3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.cgh.2008.05.006","article-title":"The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma","volume":"6","author":"Erkan","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2025030417560371700_r4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/MPA.0000000000000335","article-title":"Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels","volume":"44","author":"Miura","year":"2015","journal-title":"Pancreas"},{"key":"2025030417560371700_r5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","article-title":"Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer","volume":"19","author":"Lesina","year":"2011","journal-title":"Cancer Cell"},{"key":"2025030417560371700_r6","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1158\/0008-5472.CAN-12-4601","article-title":"Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner","volume":"73","author":"Mace","year":"2013","journal-title":"Cancer Res."},{"key":"2025030417560371700_r7","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/labinvest.3700191","article-title":"Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice","volume":"84","author":"Nagashio","year":"2004","journal-title":"Lab. Invest."},{"key":"2025030417560371700_r8","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med."},{"key":"2025030417560371700_r9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nrc3603","article-title":"The roles of TGF\u03b2 in the tumour microenvironment","volume":"13","author":"Pickup","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"2025030417560371700_r10","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.4049\/jimmunol.173.6.3844","article-title":"IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation","volume":"173","author":"Park","year":"2004","journal-title":"J. Immunol."},{"key":"2025030417560371700_r11","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1158\/0008-5472.CAN-06-3963","article-title":"Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation","volume":"67","author":"Bharadwaj","year":"2007","journal-title":"Cancer Res."},{"key":"2025030417560371700_r12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00262-011-1028-0","article-title":"Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13","volume":"60","author":"Gabitass","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"2025030417560371700_r13","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","article-title":"Significance of M2-polarized tumor-associated macrophage in pancreatic cancer","volume":"167","author":"Kurahara","year":"2011","journal-title":"J. Surg. Res."},{"key":"2025030417560371700_r14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/bjc.2016.42","article-title":"Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients","volume":"114","author":"Loskog","year":"2016","journal-title":"Br. J. Cancer"},{"key":"2025030417560371700_r15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/CJI.0b013e31829d8a1b","article-title":"Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma","volume":"36","author":"Westberg","year":"2013","journal-title":"J. Immunother."},{"key":"2025030417560371700_r16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00262-013-1507-6","article-title":"Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand","volume":"63","author":"Liljenfeldt","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"2025030417560371700_r17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/gt.2016.80","article-title":"Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment","volume":"24","author":"Eriksson","year":"2017","journal-title":"Gene Ther."},{"key":"2025030417560371700_r18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.cgt.7701117","article-title":"Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I\/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region","volume":"15","author":"Danielsson","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"2025030417560371700_r19","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","article-title":"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells","volume":"185","author":"Lechner","year":"2010","journal-title":"J. Immunol."},{"key":"2025030417560371700_r20","doi-asserted-by":"crossref","first-page":"10013","DOI":"10.1128\/JVI.79.15.10013-10022.2005","article-title":"The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35","volume":"79","author":"Fleischli","year":"2005","journal-title":"J. Virol."},{"key":"2025030417560371700_r21","doi-asserted-by":"crossref","first-page":"e42699","DOI":"10.1371\/journal.pone.0042699","article-title":"Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"key":"2025030417560371700_r22","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3748\/wjg.v20.i9.2237","article-title":"Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies","volume":"20","author":"Rucki","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"2025030417560371700_r23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/sj.onc.1201307","article-title":"Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions","volume":"15","author":"Kornmann","year":"1997","journal-title":"Oncogene"},{"key":"2025030417560371700_r24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/etm.2010.181","article-title":"Therapeutic potential of the TWEAK\/Fn14 pathway in intractable gastrointestinal cancer","volume":"2","author":"Yoriki","year":"2011","journal-title":"Exp. Ther. Med."},{"key":"2025030417560371700_r25","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00262-011-1178-0","article-title":"Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth","volume":"61","author":"Porembka","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"2025030417560371700_r26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/cgt.2014.2","article-title":"CD40L gene therapy tilts the myeloid cell profile and promotes infiltration of activated T lymphocytes","volume":"21","author":"Liljenfeldt","year":"2014","journal-title":"Cancer Gene Ther."},{"key":"2025030417560371700_r27","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.molonc.2015.10.008","article-title":"Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy","volume":"9","author":"\u015aledzi\u0144ska","year":"2015","journal-title":"Mol. Oncol."},{"key":"2025030417560371700_r28","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"2025030417560371700_r29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"2025030417560371700_r30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccr.2011.03.002","article-title":"Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression","volume":"19","author":"Fukuda","year":"2011","journal-title":"Cancer Cell"},{"key":"2025030417560371700_r31","first-page":"2449","article-title":"Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells","volume":"21","author":"Miyamoto","year":"2001","journal-title":"Anticancer Res."},{"key":"2025030417560371700_r32","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4161\/cbt.6.7.4328","article-title":"IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells","volume":"6","author":"Feurino","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"2025030417560371700_r33","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","article-title":"Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma","volume":"145","author":"Ene-Obong","year":"2013","journal-title":"Gastroenterology"},{"key":"2025030417560371700_r34","first-page":"925s","article-title":"Systemic and local immunosuppression in pancreatic cancer patients","volume":"7","author":"von Bernstorff","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"2025030417560371700_r35","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2025030417560371700_r36","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","article-title":"Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma","volume":"33","author":"Royal","year":"2010","journal-title":"J. Immunother."},{"key":"2025030417560371700_r37","doi-asserted-by":"crossref","first-page":"18508","DOI":"10.18632\/oncotarget.7610","article-title":"Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model","volume":"7","author":"Luheshi","year":"2016","journal-title":"Oncotarget"},{"key":"2025030417560371700_r38","doi-asserted-by":"crossref","first-page":"32884","DOI":"10.18632\/oncotarget.15862","article-title":"Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and suppresses metastasis of lung cancer cells","volume":"8","author":"Lau","year":"2017","journal-title":"Oncotarget"},{"key":"2025030417560371700_r39","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/0008-5472.CAN-15-2840","article-title":"IL6 blockade reprograms the lung tumor microenvironment to limit the development and progression of K-ras-mutant lung cancer","volume":"76","author":"Caetano","year":"2016","journal-title":"Cancer Res."},{"key":"2025030417560371700_r40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1476-4598-12-103","article-title":"Oncolytic viruses as therapeutic cancer vaccines","volume":"12","author":"Bartlett","year":"2013","journal-title":"Mol. Cancer"},{"key":"2025030417560371700_r41","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1158\/1078-0432.CCR-10-0385","article-title":"AdCD40L immunogene therapy for bladder carcinoma\u2013the first phase I\/IIa trial","volume":"16","author":"Malmstrom","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"2025030417560371700_r42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/CJI.0b013e3181acea69","article-title":"Local AdCD40L gene therapy is effective for disseminated murine experimental cancer by breaking T-cell tolerance and inducing tumor cell growth inhibition","volume":"32","author":"Lindqvist","year":"2009","journal-title":"J. Immunother."},{"key":"2025030417560371700_r43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0192-0561(98)00005-8","article-title":"IL-6 functions in cynomolgus monkeys blocked by a humanized antibody to human IL-6 receptor","volume":"20","author":"Imazeki","year":"1998","journal-title":"Int. J. Immunopharmacol."},{"key":"2025030417560371700_r44","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3748\/wjg.v22.i9.2678","article-title":"Key players in pancreatic cancer-stroma interaction: cancer-associated fibroblasts, endothelial and inflammatory cells","volume":"22","author":"Nielsen","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"2025030417560371700_r45","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3748\/wjg.14.2023","article-title":"Pancreatic stellate cells promote proliferation and invasiveness of human pancreatic cancer cells via galectin-3","volume":"14","author":"Jiang","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"2025030417560371700_r46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1158\/2326-6066.CIR-14-0150","article-title":"Galectin-3 shapes antitumor immune responses by suppressing CD8+ T cells via LAG-3 and inhibiting expansion of plasmacytoid dendritic cells","volume":"3","author":"Kouo","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"2025030417560371700_r47","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/carcin\/bgu122","article-title":"The role of the hepatocyte growth factor\/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer","volume":"35","author":"Patel","year":"2014","journal-title":"Carcinogenesis"},{"key":"2025030417560371700_r48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/eji.201242603","article-title":"Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects","volume":"43","author":"Klein","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"2025030417560371700_r49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00262-010-0954-6","article-title":"Monocyte-derived DC maturation strategies and related pathways: a transcriptional view","volume":"60","author":"Castiello","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"2025030417560371700_r50","doi-asserted-by":"crossref","first-page":"e955331","DOI":"10.4161\/21624011.2014.955331","article-title":"Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14+ PD-L1+ phenotype in prostate cancer","volume":"3","author":"Spary","year":"2014","journal-title":"OncoImmunology"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/202\/3\/787\/61872436\/ji1800717.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/202\/3\/787\/61872436\/ji1800717.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:05:10Z","timestamp":1741115110000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/202\/3\/787\/7953760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1800717","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2019,2,1]]}}}